Related Experiment Video
Updated: Aug 4, 2025

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Cardiovascular Diseases
Angelo Armandi1, Elisabetta Bugianesi1
1Department of Medical Sciences, University of Turin, Corso Dogliotti 14, Torino 10126, Italy.
Insights
Patients with nonalcoholic fatty liver disease (NAFLD) face increased cardiovascular risks like atherosclerosis and heart failure. Liver injury severity influences this risk, highlighting the need for integrated management strategies.
Area of Science:
- Cardiology
- Hepatology
- Metabolic Syndrome
Background:
- Nonalcoholic fatty liver disease (NAFLD) is linked to elevated cardiovascular disease (CVD) risk, including atherosclerosis, coronary artery disease, heart failure, and arrhythmias.
- This heightened risk is partly attributed to shared risk factors but is significantly modulated by the degree of liver injury.
Purpose of the Study:
- To explore the mechanisms by which liver injury in NAFLD contributes to cardiovascular complications.
- To emphasize the need for unified diagnostic and management approaches for cardiovascular risk in NAFLD patients.
Main Methods:
- Review of existing literature on the interplay between NAFLD, metabolic inflammation, and cardiovascular pathology.
- Analysis of how factors like diet and genetic polymorphisms exacerbate CVD risk in NAFLD.
Main Results:
- Fatty liver can promote an atherogenic profile.
- Nonalcoholic steatohepatitis (NASH) necro-inflammation can worsen systemic metabolic inflammation.
- Fibrosis progression in the liver may parallel myocardial changes, preceding heart failure.
Conclusions:
- The cardiovascular risk in NAFLD is multifactorial, involving shared risk factors, diet, genetics, and the specific liver pathology.
- Integrated clinical and diagnostic strategies are essential for effectively managing cardiovascular risk in individuals with NAFLD.
Abstract:
Patients with nonalcoholic fatty liver disease (NAFLD) are at high risk of cardiovascular disease, including carotid atherosclerosis, coronary artery disease, heart failure, and arrhythmias. The risk is partially due to shared risk factors, but it may vary according to liver injury. A fatty liver may induce an atherogenic profile, the local necro-inflammatory changes of nonalcoholic steatohepatitis may enhance systemic metabolic inflammation, and fibrogenesis can run parallel in the liver and in the myocardium and precedes heart failure. The detrimental impact of a Western diet combines with polymorphisms in genes associated with atherogenic dyslipidemia. Shared clinical/diagnostic algorithms are needed to manage the cardiovascular risk in NAFLD.
More Related Videos
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Coronary Artery Disease I: Introduction
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease II: Pathophysiology